A Rare Case Report: Spinal Metastasis of Anaplastic Pleomorphic Xanthoastrocytoma
Article Sidebar
Main Article Content
Abstract
Anaplastic Pleomorphic Xanthoastrocytoma is a very rare tumor of the Central Nervous System (CNS). BRAFV600E mutation is a common mutation in pleomorphic xanthoastrocytoma. We present a 52-year-old male patient who underwent total resection due to a temporal lobe mass. The primary tumor in the temporal lobe was given postoperative radiotherapy. During follow-up, genetically and histologically proven metastasis was detected in the paraspinal region. The adjuvant RT was given to metastasis after surgery. The patient, who used the combination of dabrafenib and trametinib after recurrence, is being monitored in remission.
Article Details
Copyright (c) 2025 Kavak G, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251. Available from: https://doi.org/10.1093/neuonc/noab106
Rudà R, Capper D, Waldman AD, Pallud J, Minniti G, Kaley TJ, et al. EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors. Neuro Oncol. 2022;24(12):2015-2034. Available from: https://doi.org/10.1093/neuonc/noac188
Ida CM, Rodriguez FJ, Burger PC, Caron AA, Jenkins SM, Spears GM, et al. Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up. Brain Pathol. 2015;25(5):575-586. Available from: https://doi.org/10.1111/bpa.12217
Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol. 2011;121(3):397-405. Available from: https://doi.org/10.1007/s00401-011-0802-6
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949-954.
Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O'Neill BP. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer. 1999;85(9):2033-2045. Available from: https://doi.org/10.1038/nature00766
Yuan E, Lo E, Vartanians T, Chen T, Chow F. Anaplastic Pleomorphic Xanthoastrocytoma with Extracranial Bone Metastasis: A Case Report and Literature Review (P15-9.004). Neurology. 2022;98(18_supplement):1251. Available from: http://dx.doi.org/10.1212/WNL.98.18_supplement.1251
Zagardo V, Viola A, Scalia G, Palmisciano P, Umana GE, Ferini G. Recurrent Pleomorphic Xanthoastrocytoma Presenting with Diffuse Leptomeningeal Spread. Neurohospitalist. 2024;14(4):468-470. Available from: https://doi.org/10.1177/19418744241273267
Foo J, Ng WH. Metastatic pleomorphic xanthoastrocytoma in the scalp. J Clin Neurosci. 2011;18(4):565-567. Available from: https://doi.org/10.1016/j.jocn.2010.08.008
Wu X, Yokoyama K, Sumita K, Tanaka Y, Tateishi U. Intraventricular Pleomorphic Xanthoastrocytoma: A Case Report and Systemic Review. Cureus. 2024;16(1):e52510. Available from: https://doi.org/10.7759/cureus.52510
Gill M, Pathak HC, Madan R, Bhattacharya S, Choudhary GS. Primary spinal pleomorphic xanthoastrocytoma. Neurol India. 2010;58(5):771-773. Available from: https://doi.org/10.4103/0028-3886.72193
Herpers MJ, Freling G, Beuls EA. Pleomorphic xanthoastrocytoma in the spinal cord. Case report. J Neurosurg. 1994;80(3):564-569. Available from: https://doi.org/10.3171/jns.1994.80.3.0564
Nakamura M, Chiba K, Matsumoto M, Ikeda E, Toyama Y. Pleomorphic xanthoastrocytoma of the spinal cord. Case report. J Neurosurg Spine. 2006;5(1):72-75. Available from: https://doi.org/10.3171/spi.2006.5.1.72
Das S, Yip S, Hukin J, Cochrane D, Dunham C. Pleomorphic xanthoastrocytoma of the spinal cord: case report and literature review. Clin Neuropathol. 2014;33(3):190-196. Available from: https://doi.org/10.5414/np300689
Han W, Jin Y, Wang J, Zhang S, Hashimoto S, Wang Z, et al. Proton Beam Therapy for A Rare Anaplastic Pleomorphic Xanthoastrocytoma: Case Report and Literature Review. Int J Part Ther. 2024:100736. Available from: http://dx.doi.org/10.1016/j.ijpt.2024.100736
Migliorini D, Aguiar D, Vargas MI, Lobrinus A, Dietrich PY. BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma. Neurology. 2017;88(13):1291-1293. Available from: https://doi.org/10.1212/WNL.0000000000003767
Wen PY, Stein A, van den Bent M, De Greve J, Wick A, de Vos FYFL, et al. Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial. Lancet Oncol. 2022;23(1):53-64. Available from: https://doi.org/10.1016/s1470-2045(21)00578-7